Accelerate Your Clinical Research Projects

Efficient Regulatory Assessment

Health Canada’s Key Role

In Canada, including in Quebec, Health Canada is the federal authority responsible for regulating clinical trials involving drugs, biologics, medical devices, and natural health products. Its responsibilities include authorizing commercial releases, monitoring adverse effects, managing recalls and inspections, as well as regulating the purchase and use of these products.

Sponsors that submit an initial application or change in protocol generally receive regulatory approval within 30 days. This efficiency is based on a clear political commitment that demonstrates Canada’s willingness to make clinical research a strategic priority and favour fast approval of the trials in the country.

A Fast Regulatory Approval Process

Basic research
Preclinical research
Health Canada Regulatory Review (CTA or ITA) ≤ 30 days
Clinical research
Federal review (Health Canada)
Provincial review and access to market
last-image

CATALIS QUÉBEC | © 2026. All rights reserved.

This content is the property of CATALIS QUÉBEC and may not be reproduced, copied, published, or distributed without permission.